The EmulSiv™ filter removes microbial contamination from propofol but is not a substitute for aseptic technique

Canadian Journal of Anesthesia

Volumn 50, Issue 6, 2003, Pages 541-546

  Hall, Wendy C E ^a   Jolly, Donald T ^a   Hrazdil, Jiri ^b   Galbraith, John C ^b   Greacen, Maria ^b   Clanachan, Alexander S ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ARTICLE; ASEPSIS; BACTERIAL COUNT; BACTERIUM CULTURE; CALIBRATION; CAMPYLOBACTER JEJUNI; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG CONTAMINATION; ESCHERICHIA COLI; FILTER; FILTRATION; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; MICROBIAL CONTAMINATION; MORAXELLA; MORAXELLA CATARRHALIS; NONHUMAN; PANTOEA AGGLOMERANS; PRIORITY JOURNAL; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BACTERIUM; HUMAN; ISOLATION AND PURIFICATION;

BACTERIA; COLONY COUNT, MICROBIAL; DRUG CONTAMINATION; FILTRATION; HUMANS; PROPOFOL;

EID: 0043132420     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018637     Document Type: Article

References (25)

1. Morgan GE Jr, Mikhail MS. Anesthetic complications. In: Morgan GE Jr, Mikhail MS (Eds.). Clinical Anesthesiology, 2nd ed. New York: Lange Medical Books/McGraw Hill; 1996: 760.
2. Carr S, Waterman S, Rutherford G, et al. Postsurgical infection associated with an extrinsically contaminated intravenous anesthetic agent-California, Illinois, Maine and Michigan. MMWR Mor Mortal Wkly Rep 1990; 39: 426-7, 433.
3. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333: 147-54.
4. Gillis MC. Diprivan®. In: Gillis MC, (Ed.). Compendium of Pharmaceuticals and Specialties 34th ed. Ottawa, Ontario: Pharmacists Association; 1999: 539-43.
5. Nichols R, Smith J. Bacterial contamination of an anesthetic agent (Editorial). N Engl J Med 1995; 333: 184-5.
6. Veber B, Gachot B, Bedos JP, Wolff M. Severe sepsis after intravenous injection of contaminated propofol (Letter). Anesthesiology 1994; 80: 712-13.
7. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology, 7th ed. Washington: D.C., ASM Press; 1999.
8. Holt JG, Krieg NR, Sneath PHA, Staley JT, Willliams ST. Bergey's Manual of Determinative Bacteriology 9th ed. Baltimore: Williams and Wilkins; 1994.
9. Nachamkin I. Campylobacter and acrobacter. In: Murray PR, Baron EJ, Pfaller MA, Tennover FC, Yolken RH (Eds.). Manual of Clinical Microbiology, 7th ed. Washington: ASM Press; 1999: 716-26.
10. Carbone-Traber KB, Shanks CA. Glass particle contamination in single-dose ampules. Anesth Analg 1986; 65: 1361-3.
11. Goodale DB. Propofol: can a single ampule be used for multiple patients? (Letter reply) Anesthesiology 1991; 74: 1156-7.
12. McHugh GJ, Roper GM. Propofol emulsion and bacterial contamination. Can J Anaesth 1995; 42: 801-4.
13. Zacher AN, Zornow MH, Evans G. Drug contamination from opening glass ampules. Anesthesiology 1991; 75: 893-5.
14. Kempen PM, Sulkowski E, Sawyer RA. Glass ampules and associated hazards. Crit Care Med 1989; 17: 812-3.
15. Bach A, Motsch J. Infectious risks associated with the use of propofol. Acta Anaesthesiol Scand 1996; 40: 1189-96.
16. Webb SAR, Roberts B, Breheny FX, Golledge CL, Cameron PD, Van Heerden PV. Contamination of propofol infusions in the intensive care unit: incidence and clinical significance. Anaesth Intensive Care 1998; 26: 162-4.
17. Bach A, Motsch J, Schmidt H, et al. In-use contamination of propofol. A clinical study. Eur J Anaesthesiol 1997; 14: 178-83.
18. Lorenz IH, Kolbitsch C, Lass-Florl C, et al. Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer's recommendations. Can J Anesth 2002; 49: 347-52.
19. Kolbitsch C, Lass-Florl C, Benzer A. Propofol and post-operative infections. (Letter). N Engl J Med 1995; 333: 1506-7.
20. Rosenberg AD, Bernstein RL, Ramanathan S, Albert DB, Marshall MH. Do anesthesiologists practice proper infection control precautions? Anesthesiology 1989; 71(Suppl): A949.
21. Kempen PM, Learned DW. Anesthesia practice - a vector of infection? Anesthesiology 1989; 71(Suppl): A948.
22. Barnett M, Cohen J. Filtration of lipid containing total parenteral nutrition (TPN) admixtures. Clinical Nutrition 1995; 14: 49.
23. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol 1984; 19: 17-20.
24. Arduino MJ, Bland LA, McAllister SK, et al. Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol 1991; 12: 535-9.
25. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-601.